Sabby Management’s Zomedica Corp. ZOM Stock Holding History

Sabby Management’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-470,548	Closed	-$52K	–	168
2020 Q3	$52K	Buy	+470,548	New	+$64.8K	0.01%	124

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management's ZOM Position: Q4 2020 in Review

Sabby Management sold out of Zomedica Corp. (ZOM) in Q4 2020, closing a stake of 470,548 shares — an estimated $52K sold.

Sabby Management first reported a position in ZOM in Q3 2020 and held it in 1 quarter. The position peaked at $52K in Q3 2020. 38 funds tracked by Wall St. Rank hold ZOM as of Q4 2020.

Sabby Management reported no remaining Zomedica Corp. position as of Q4 2020 after selling out during the quarter.
Sabby Management sold 470,548 Zomedica Corp. shares in Q4 2020, an estimated $52K.
Sabby Management first reported a position in Zomedica Corp. in Q3 2020 and held it in 1 quarter.
Sabby Management's Zomedica Corp. position peaked at $52K in Q3 2020.
38 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.